FDA Inspection 1173712 — Sahil (Nmi) Khanna, MBBS, MS, Clinical Investigator

Sahil (Nmi) Khanna, MBBS, MS, Clinical Investigator — FEI 3022160354

The FDA completed an inspection of Sahil (Nmi) Khanna, MBBS, MS, Clinical Investigator on Jun 10, 2022 in Rochester, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 10, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Rochester, MN (United States)

Additional Details

Clinical Investigator (CI)